ADMA
ADMA Biologics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.90B
P/E Ratio
12.07
EPS
$0.68
Beta
0.73
52W High
$20.97
52W Low
$7.21
50-Day MA
$9.26
200-Day MA
$14.54
Dividend Yield
—
Profit Margin
32.40%
Forward P/E
10.02
PEG Ratio
0.00
About ADMA Biologics Inc
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.
Fundamentals
| Revenue (TTM) | $509.86M |
| Gross Profit (TTM) | $312.42M |
| EBITDA | $214.82M |
| Operating Margin | -123.40% |
| Return on Equity | 43.30% |
| Return on Assets | 22.00% |
| Revenue/Share (TTM) | $2.14 |
| Book Value | $1.68 |
| Price-to-Book | 4.94 |
| Price-to-Sales (TTM) | 3.73 |
| EV/Revenue | 3.912 |
| EV/EBITDA | 9.00 |
| Quarterly Earnings Growth (YoY) | -52.80% |
| Quarterly Revenue Growth (YoY) | 15.90% |
| Shares Outstanding | $231.77M |
| Float | $226.71M |
| % Insiders | 1.87% |
| % Institutions | 93.95% |
Historical Volatility
HV 10-Day
38.67%
HV 20-Day
34.61%
HV 30-Day
63.28%
HV 60-Day
81.41%
HV Rank
82.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($17.60 target)
3
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026